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fhe physiologic Basis for Nutritional Support in Hepatic Failure 
John J. Fath, MD, MPH* 
Hepatic failure is often perceived as a unldimensional progression from near normal clinical function 
(Child's class A) to overt clinical failure (Child's class C). As this view fails to distinguish berween 
patients who are capable of using exogenous protein and those who cannot, it hinders the nutritional 
support team in determining protein supplementation. This report addresses the physiologic basis for 
variable findings in hepatic failure and proposes a .simple definition of hepatic fadure based upon 
ability lo utilize amino acids. (Henry Ford Hosp MedJ 1990:38:229-34) 
Chronic hepatic failure is often viewed as a unidimensional failure of hepatic organ function related solely to loss of he-
patic parenchymal volurae. While perhaps correct for certain as-
pects of hepatic function, this view fails to account for the cora-
plex nature ofthe hepatic role in the body's responses to differ-
ent metabolic or nutritional settings. Such a liraited view may 
lead to inappropriate restriction of protein intake. What follows 
is an attempt to place the coraplex nature of hepatic failure into 
a framework of metabolic responses. By depicting the hepatic 
role in the body's normal responses to certain metabolic or nu-
tridonal settings, it hopefully will be easier to understand the 
body's responses to the failing liver. 
Hepatic Use of Nutritional Substrates 
The Hver has many different pathways available for the me-
tabohsra of any particular substrate. How it uses substrates de-
pends on the horraonal control over these pathways (1). In gen-
eral, the pathways tend to lead either to storage or acute use. The 
carbohydrate pathways, potentially the siraplest, become com-
plex as the available precursors change. For example, in the fed 
state, sufficient glucose is available to allow glycogen formation 
and to supply glucose for peripheral use. Fasting leads to glyco-
genolysis, and glucose presenting to the liver via the arterial or 
portal system during fasting tends to be exported for peripheral 
use. In starvation, precursors for glucose production becorae 
scarce, and araino acids (from protein degradation) or glycerol 
(from fat metabolism) becorae the raain gluconeogenic precur-
sors. The pathways for fat raetabolisra are sirailarly controlled 
hut made raore complex by the need to coordinate formation of 
hoth triglyceride and transport proteins to allow storage at the 
peripheral lipocytes. 
Control over protein metabolism is different in that there is no 
'storage site for protein coraparable to glycogen or fat. Muscle 
hecomes a repository of intracellular free araino acids and ex-
pendable protein (2,3). In fed states, rauscle takes up free araino 
"eids. Muscle protein is raade not for storage but as a response to 
e'^ ercise. In injury or sepsis, amino acids are released and raus-
Table 
Relative Rates of Metabolic Processes in Sepsis/Injury, 
Starvation, and Hibernation 
Metabolic Slale Sepsis/Injury Starvation Hibernation 
Mu.scle protein catabolism - l - l - + — 
Vi,sceral protein catabolism + - l - l -
— 
Gluconeogenesis -I-++ -t- -1-
Lipolysis -1- -I-++ ++-I-
Protein synthesis ++ -1- -I -
Note: The number of "-(-" markings indicate the rate of thai process relative to the other 
metabolic stales. The "—markings signify an increase in lean body mass. 
cle protein is catabolized (Table). In starvation, organ protein 
frora the kidney, gut, and liver is catabolized to a greater extent 
while rauscle protein is catabolized at a slower rate (1). The 
liver's role in these raetabolic states is govemed by coraplex 
hormonal interactions which are not yet well understood. 
Normal Metabolic States 
The various alternate pathways for hepatic substrate are pres-
ent to allow adaptation to the different environmental settings 
organisms face. One exaraple is the fed versus fasting state. Fed 
aniraals use nutrients for current needs and shunt the remainder 
to storage. Fasting animals use glycogen and free amino acids 
and begin mobilizing fat stores. A shift away frora a glucose-in-
tensive raetabolisra does not occur until starvation ensues. 
Starvation and hibernation are two examples of long-term 
raetabolic states (4). Both are fat-dependent and attempt to spare 
rauscle protein. Hibernation actually increases lean body mass 
Submitted for publication: January 26. 1990. 
Accepted for publication: August 8, 1990, 
*Division of Trauma and Crilical Care Surgery, Henry Ford Hospital, 
Address correspondence lo Dr, Fath, Division of Trauma and Critical Care Surgery, 
Henry Ford Hospital. 2799 W Grand Blvd, Detroit, MI 48202, 
.^ _-Fachiii' I Ford Hosp Med J—Vol ,38, No 4, 1990 Nutritional Support in Hepatic Failure—Fath 229 
as a raeans to prevent urea forraation. The metabolic states of 
starvation and hibernation both tend to preserve stores as rauch 
as possible. 
In contrast, the response to fear is a mobilization state (5). 
Glucose and amino acids are rapidly released to provide acute 
energy for brain and rauscle. The response to provide energy for 
short-term muscle reaction in tiraes of extraordinary need is 
shifted after injury to provide short-terra energy for reparative 
processes (1,6). The response to injury is not a conservative one 
and never shifts to a fat-based raetabolisra. Although fat is used, 
glycerol and araino acids are necessary to maintain gluconeo-
genesis. Muscle protein catabolism fuels gluconeogenesis and 
provides for hepatic synthesis of acute phase proteins. The re-
sponse to injury and sepsis becoraes a nitrogen-wasting raetabo-
lisra at the expense of rauscle protein despite high hepatic syn-
thesis rates (3,5). It is also directed toward an anaerobic repara-
tive process at the local wound level. The systeraic effects of 
horraonal raessengers released to guide the local repair process 
may partially explain the oxidative metabolic "defect" (7) seen 
in sepsis and hepatic failure. From the standpoint of hepatic in-
volveraent in such processes, its capacity to re.spond is large. 
Hepatic response is likely related to the level of hormonal stimu-
lation rather than to parenchymal mass. 
Control Over Metabolism 
The orchestration of these various raetabolic states is con-
trolled by several systeras which are responding to stirauli on 
different fronts (I). The portal systera allows siraple feedback 
control over insulin and glucagon release during cycles of feed-
ing or fasting. The triggers for hibemation are not clear but raost 
likely are related to steroid horraonal control. The neuroendo-
crine axis initiates the flight/fight response (5). Hepatic involve-
raent in the various raetabolic responses requires sensitivity to 
raultiple control stimuli (I). The liver has a direct autonoraic 
nervous system innervation. Direct neural respon,ses are imme-
diate as in the "flight or fight" response. Arterial plasma brings 
classic neuroendocrine hormones, catecholaraines, and lyra-
phokines. Portal flow brings pancreas and gut horraones as well 
as lyraphokines frora the extensive gut lymphatics. This endo-
crine raetabolic response provides for long duration responses 
as in septic states or tissue injury (8). The hepatic response to 
any hormone can be affected by raany factors including body 
teraperature, hepatic energy state, precursor supply, receptor 
status, hepatic blood flow, and the balance of other horraones 
acting concurrently. Although the layers of control are coraplex 
and readily perturbed, the parenchyraal metabolic raachinery 
has a large capacity and requires extensive cell loss before the 
basic raetabolic functions cease. 
Control Over Portal System 
The liver is not a passive component in the network of raeta-
bolic control. It commands the venous exit site frora the portal 
system and effectively isolates portal venous circulation from 
systemic circulation. Appropriate interaction between the two 
environments, portal and systeraic, is dependent upon hepatic 
function. Sometiraes hepatic function entails reducing high con-
centrations of portal substrates to levels tolerated by the orgg^ j 
of systemic circulation. At other times the liver controls the sy^ . 
temic levels of a substrate by synthesis. Systemic glucose levejj 
are a common example of hepatic control, but levels of raost cir. 
culating substrates are controlled by the liver in one way or gj,. 
other. Hepatic control over plasraa levels of substrates provides 
feedback to systeraic horraonal control systeras. Failure of tiij 
liver to control portal circulation output can alter the body'j 
metabolic state by dismpting these feedback mechanisras. 
Immune Functions 
The liver can exert raetabolic control indirectly through Knupf. 
fer cell interactions. Iraraunologic functions ofthe Kupffer cell 
systera include local control over portal systera bacteremias and 
sorae processing of peritoneal and systemic antigens. White cell 
mediated activation of the stress response can thus affect tts; 
liver through local or systemic action (8). Laboratory data sup-
port a direct Kupffer cell action upon adjacent hepatocytes, witb 
potentially destructive or inhibitory action as well as activation 
of stress raetabolisra (9). The potential systemic effects of portal 
blood shunting away frora the Kupffer cell systera have not been 
well studied but could be responsible for activating the iramune 
systera on a systeraic level. 
Testing Hepatic Function 
Current hepatic function tests do not assess the various con-
trol systems which influence hepatic function. Determining how 
well the liver is performing in any metabolic state is difficult 
without knowing the degree of stimulus for any single function. 
Some hepatic functions are not extensively supported and, lilce 
ethanol raetabolisra, are readily saturated (10). Other functions 
are concentration gradient phenoraena and can be altered by 
siraple changes in hepatic blood flow (11). Detoxification of 
sorae drugs is linearly related to blood flow or parenchymal 
mass. Several clearance tests have been purported to be for he' 
patic function, but they either lack specificity or fail to distin-
guish between parenchyraal raass and blood flow changes. Clin-
ically, such tests do not provide inforraation regarding hepatic 
ability to recover frora or tolerate stress. While raetabolic clear-
ance tests, such as plasraa amino acid clearance, have defflo^ 
strated good correlation with hepatic function in severe stress 
(12-15), they do have limitations. For example, plasma amino 
acid clearance is useful only in the late stages of hepatic failuf^ ' 
Because of the varied functions of the liver, any single test is i * 
likely to provide all the information that clinicians may requf' 
for an accurate prognosis. 
upf. 
Complex Versus Basic Functions 
Complex functions, such as those described above, repn •eseni 
the controlling aspects of hepatic raetabolisra. Basic functio 
such as gluconeogenesis, protein synthesis, araino acid uptal"' 
and triglyceride production, are the controlled functions. SucM 
categorization of functions has value in that the capacity for''^ 
sic hepatic functions is well supported within the parenchyi"^  
mass and requires extensive loss of parenchyma to reach 
gerous levels. 
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} Central plasma amino acid clearance rates of patients 
undergoing operative procedures. Patients are elassified by 
Child's class and by their survival postoperatively. Note that 
survival was related to an increased ability to use amino acids 
as the clinical hepatic failure worsened. (Data from Pearl et al 
l!2].) 
A third category, intermediate functions, includes functions 
that are neither directly involved in stress metabolism nor a part 
ofthe controlling process. For exaraple, functions such as drug 
detoxification and bile raetabolisra raay be sensitive to changes 
in blood flow or enzyme induction ( I I ) , but they are not neces-
sarily the determining factors in survival when altered during 
stress metabolism. 
Assessment of Hepatic Function 
Most liver function tests that clinicians use do not assess the 
capacity ofthe basic hepatic raetabolic system. As a result, tests 
such as serum bilirubin or hepatic enzyraes raay suggest hepatic 
failure when the parenchyraal raass is adequate for raetabolic 
function. Pearl et al (12) reported that patients with the sarae 
Child's classification often had raarkedly different capacities to 
use amino acids. (Child's classification is a clinical categoriza-
tion of patients based upon presence of ascites and hepatic en-
cephalopathy, the patient's nutritional status, and values for se-
rum bilirubin and alburain. A Child's class C patient raay have 
uncontrolled ascites, rauscle wasting, raarked hepatic encepha-
lopathy, serura bilirubin > 3.0 g/dL, and serura alburain < 3.0 
g/dL.) These authors noted that postoperative survival related 
"tore to the body's ability to use araino acids rather than the pa-
tient's Child's classification (Fig I). What has "failed," then, is 
the control over raetabolisra. Instead of the standard metabolic 
patterns, a different raetabolisra appears due to alterations in the 
"lore complex control systems. 
The cause of such failure is not known, but several raecha-
tisms are possible. Shunting of portal blood to a systeraic pool 
"•ay allow toxins, usually cleared by hepatic systeras, to stirau-
'ate peripheral iraraune cells and set up a systemic stress re-
•'Ponse. Portal horraones which norraally are cleared by the liver 
"lay pass to the systeraic circulation and alter the horraonal bal-
'^"^ e. In tum, peripheral horraonal instructions raay be inter-
P'^ eted incorrectly by the corapromised liver. Complex func-
mg Nl 9 hr/ kg 
(B) 
Fig 2—Comparison between patients with hepatic cirrhosis and 
control subfects at two different dietary compositions: A) 1 g 
protein/kg/day; B) 0.5 g protein/kg/day. (Data from Swart et al 
[20].) 
tions of the liver raay be related to parenchyraal mass, yet it is 
more likely that the balance of hormonal control from portal and 
systemic input becoraes deranged. The result is a maladaptive 
metabolism that approximates the stress response in its heraody-
naraic characteristics (16-18) and in the hypermetabolic protein 
wasting that occurs. Clinically, the ability to estiraate the level 
of raetabolic stress and changes in the controlling milieu is cur-
rently limited to nitrogen excretion studies (19). Hormonal and 
amino acid levels have been used in categorization schemes but 
are seldom available clinically. 
Definition of Two Stages of Hepatic Failure 
The above definitions allow breakdown of hepatic failure into 
two siraple stages: early hepatic failure and late hepatic failure. 
Early hepatic failure involves progressive irapairraent of com-
plex and intermediate functions. Alteration of the complex liver 
functions leads to a stress-style raetabolisra. Swart et al (20) 
have demonstrated increased protein synthesis and rapid protein 
breakdown in patients with hepatic failure when compared to 
control subjects. This increase was noted in patients on protein 
supplemented diets (1 g/kg) (Fig 2A) as well as in those on pro-
tein-restricted diets (Fig 2B). These data suggest that raany pa-
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Fig 3—Plasma levels of aldosterone in patients with hepatic 
cirrhosis and control subjects. Note the plasma level response 
to albumin Infusion. (Data from Wong etal [24].) 
tients with hepatic failure actually have increa.sed hepatic pro-
tein metabolism when corapared to patients with normal hepatic 
function. Clinical assessment of araino acid clearance deraon-
strates increased clearance by patients with hepatic cirrhosis 
corapared to nonstressed patients (12,15). A shift to a metabo-
lism that is less effective at oxidative function raakes total body 
oxidative raetabolisra flow-dependent (18). Failure to raaintain 
such increased basic functions bodes poorly for the patient, indi-
cating the beginning of late hepatic failure. Early hepatic failure 
includes decreased ability to control complex functions and a 
shift to stress-style raetabolisra. Such a raetabolisra actually in-
crea.ses the rate of raany basic functions but does so in the con-
text of a peripheral protein-wasting stress-style raetabolisra. 
Prolongation of such a raetabolisra leads to many of the signs 
attributed to chronic hepatic failure. Decreased bile synthesis 
leads to poor fat absorption and loss of calories and fat-soluble 
vitamins (21-23). Protein synthesis, although increased, is ac-
companied by a rapid proteolysis (20). Muscle raass is con-
sumed, as in sepsis, and alburain levels fall. Hormonal irabal-
ances are seen, with high aldosterone and renin levels (24) (Fig 
3). Sodiura and water dynaraics shift, leading to a.scites formation. 
Nutrition During Early Hepatic Failure 
Complications during early hepatic failure are raainly due to 
the effects of malnutrition and portal hemodynaraics (25-28). 
Nutritional support of patients during this period is essential to 
prolonging survival. Although raost concur about suppleraenta-
tion of calories in the forra of carbohydrate and fat, much con-
troversy exists over the use of protein. Two areas of protein 
metabolism complicate our understanding of the process. It is 
known that the liver handles amino acids differentially (2). 
Branched-chain amino acids are readily metabolized by both 
hepatic and nonhepatic cells. In the altered metabolism of stress 
and hepatic failure, branched-chain amino acids may enter the 
ceUular energy pathways and be oxidized (7). Sorae araino ac-
ids, which are used more for protein synthesis and less for oxida-
tive energy, are often present in higher concentrations than in 
normal plasma. These high levels indicate that protein break-
down releases amino acids faster than they can be used, whereas 
the low plasraa levels of branched-chain araino acids indicate 
that their oxidation is delivery-dependent. This differential me 
tabolism makes more apparent the rationale for high quantitiej; 
of branched-chain araino acids and lower quantities of aromatic 
araino acids in the nutrirional suppleraentation of patients wiiij 
hepatic failure. Supporting the energy raetabolisra of both pgj: 
ripheral cells and hepatocytes aids in protein synthesis but rnm 
not decrease the catabolic activity. Protein support does alio* 
positive nitrogen balance to occur. Sorae studies suggest thf 
branched-chain araino acid enriched solutions support nitrogej 
retention better than standard amino acid content nutritional so-
lutions (29.30). The role of branched-chain araino acid solutions 
in reducing encephalopathy is less clear (19,31-38). 
Gut raetabolisra of protein raay produce different portal sub-
strates depending on the type and amino acid mix of the proteit 
Blood or red meat protein is pooriy tolerated by patients withi 
hepatic failure; equal araounts of nitrogen delivered as pl^l 
protein are rauch better tolerated (33). Protein suppleraentation 
studies are still incoraplete and no conclusive data have bees 
obtained. While raany studies support the use of special amino 
acid raixtures for patients with hepatic failure, others do not {\% 
31-38). What should be apparent is that the liver's basic meto-
bolic function is still intact enough to use calories and protein, 
because it is still producing more protein than a nonstresseJ 
liver. In an atterapt to reduce the coraplications of proteolysis 
and raalnutrition, patients should receive protein dietary supple-
ments. The type of suppleraentation is determined raainly bytle 
risk of encephalopathy. Sorae patients tolerate standard supple-
raentation well, whereas others do not. For the latter group, tbe 
cost and risks of high branched-chain solutions are justified. 
When branched-chain araino acid forraulations are used, a car-
bohydrate-based nutrition plan should be followed. Some ofthe 
conflicting reports regarding efficacy of branched-chain amino 
acid preparations may be related to u.se of fat-based plans (19). 
Late Hepatic Failure 
In the above staging system, eariy hepatic failure is depicted 
as that period when the coraplex and intermediate hepatic func-
tions are impaired, yet the capacity of the liver to perform the ba-
sic functions is actually stimulated. Late hepatic failure begins 
when the liver's capacity to perforra basic functions deterio-
rates. Unless the events responsible for deterioration to late he-
patic failure (such as sepsis or toxins) can be reversed, an inexO' 
rable progression of coraplications leading to death will ensue^  
Hypoglyceraia and raarked hyperarainoacideraia are poor prog' 
nostic signs. What confounds the study of hepatic failure is 
ability of sepsis, hepatitis, dietary indiscretion, or gastrointesO 
nai bleeding to push a patient into the late stage of hepatic tdi 
ure. Treatraent of the inciting event can often lead to recoveCj 
(39). Acute fulminant hepatic failure is an exaraple of a rap 
progression frora early to late hepatic failure which can sonj^ ^ 
tiraes be reversed. Single laboratory tests becorae useless m 
terraining outcorae. Death from hepatic failure is seldom soiw 
related to loss of hepatic function. In chronic hepatic fai'" ' 
complications of portal hypertension and infection can o^  
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Ipr patients at any stage, and routine surgical procedures are 
* pfly tolerated. Such uncontrolled variables raake prognosis 
P° p^on hepatic function tests difficult. Appropriate assess-
^ of hepatic function should include a stress level index, a 
^ atic blood flow index, and an index of the parenchymal met-
boli'- response. However, such a tripartite test has not been 
died and would still be subject to the vagaries of reversible 
'^^ rtiuli such as sepsis or hepatitis. Before conclusive data can be 
u.oined nutritional studies must be able to isolate and raonitor 
obta'"^  ' . . . . , . hepatic function in response to nutntional input. 
Summary 
The liver is a complex organ which has acquired several lay-
ers of functions during its evolution. The raetabolic aspects of 
hepatic funcrion are crucial regarding patient survival following 
injury or infection. The liver's metabolic functions are under ex-(grisive control by several systeras which are responsive to dif-
ferent stirauli. In early hepatic failure, complex hormonal con-
trol is altered into a maladaptive state of stimulated basic func-
tions in a pattern sirailar to the response to sepsis and injury. In-
termediate functions which are sensitive to loss of parenchyraal 
mass and changes in blood flow or which require support of spe-
cific protein synthesis raay becorae progressively irapaired. The 
metabolic response to early hepatic failure is termed raaladap-
tive because it leads to a progressive raalnutrition due to exten-
sive catabolism, irapaired absorption of nutrients, and shifts in 
the patterns of protein synthesis. Such a state dirainishes the 
body's ability to tolerate additional insult frora injury, infection, 
or hemorrhagic shock. Nutrition must be supported, yet differ-
ential handling of proteins and the risk of encephalopathy de-
mand caution during nitrogen suppleraentation. Although stud-
ies are not conclusive, a prudent approach to nutrition in early 
hepatic failure would include trials of standard forraulas, reserv-
ing branched-chain supplemented forraulas for those whose pre-
dilection to encephalopathy precludes the use of standard diets. 
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